Korro Joins the Russell 2000®, Russell 3000®, and Russell Microcap® Indexes
Korro to Participate in Upcoming June Investor and Scientific Conferences
Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference
Korro Bio Raises $116 Million for RNA Editing Program
Korro Bio sings to the tune of $116M for its OPERA RNA editing program
RNA-editing startup to double headcount with $116M in new VC
Development of a selection assay for small guide RNAs that drive efficient site-directed RNA editing